- Home
- CNET vs PRFX Comparison
CNET vs PRFX Comparison
Compare CNET & PRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNET
- PRFX
- Stock Information
- Founded
- CNET 2003
- PRFX 2007
- Country
- CNET Hong Kong
- PRFX Israel
- Employees
- CNET N/A
- PRFX N/A
- Industry
- CNET Advertising
- PRFX Biotechnology: Pharmaceutical Preparations
- Sector
- CNET Consumer Discretionary
- PRFX Health Care
- Exchange
- CNET Nasdaq
- PRFX Nasdaq
- Market Cap
- CNET 3.3M
- PRFX 3.6M
- IPO Year
- CNET N/A
- PRFX 2020
- Fundamental
- Price
- CNET $1.41
- PRFX $1.39
- Analyst Decision
- CNET
- PRFX Hold
- Analyst Count
- CNET 0
- PRFX 1
- Target Price
- CNET N/A
- PRFX N/A
- AVG Volume (30 Days)
- CNET 705.7K
- PRFX 185.8K
- Earning Date
- CNET 08-15-2025
- PRFX 08-14-2025
- Dividend Yield
- CNET N/A
- PRFX N/A
- EPS Growth
- CNET N/A
- PRFX N/A
- EPS
- CNET N/A
- PRFX N/A
- Revenue
- CNET $13,560,000.00
- PRFX N/A
- Revenue This Year
- CNET N/A
- PRFX N/A
- Revenue Next Year
- CNET N/A
- PRFX N/A
- P/E Ratio
- CNET N/A
- PRFX N/A
- Revenue Growth
- CNET N/A
- PRFX N/A
- 52 Week Low
- CNET $1.11
- PRFX $1.25
- 52 Week High
- CNET $4.53
- PRFX $16.63
- Technical
- Relative Strength Index (RSI)
- CNET 51.94
- PRFX 33.95
- Support Level
- CNET $1.14
- PRFX $1.25
- Resistance Level
- CNET $1.43
- PRFX $1.76
- Average True Range (ATR)
- CNET 0.16
- PRFX 0.10
- MACD
- CNET 0.01
- PRFX -0.05
- Stochastic Oscillator
- CNET 41.54
- PRFX 23.53
About CNET ZW Data Action Technologies Inc.
ZW Data Action Technologies Inc is engaged in providing Internet advertising, precision marketing, e-commerce online to offline (O2O) advertising and marketing services as well as related data and technical services to small and medium enterprises in the PRC. It offers a variety channel of advertising and marketing services through its system, including distribution of the right to use search engine marketing services, provision of online advertising placements on its web portals, provision of e-commerce O2O advertising and marketing services, and provision of other related value-added data and technical services to maximize market exposure and effectiveness for clients.
About PRFX PainReform Ltd.
PainReform Ltd is a clinical-stage specialty pharmaceutical company. It is focused on the reformulation of established therapeutics. The company's product PRF-110 is based on the local anesthetic ropivacaine, targeting the post-operative pain relief market. PRF-110 is an oil-based, viscous, clear solution that is deposited directly into the surgical wound bed before closure to provide localized and extended post-operative analgesia.